인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
A weak correlation between diffusing capacity of the lung for carbon monoxide (DL<sub>CO</sub>) and emphysema has been reported. This study investigated whether impaired DL<sub>CO</sub> in chronic obstructive pulmonary disease (COPD) is associated with increased risk of acute exacerbation independent of the presence or extent of emphysema. This retrospective cohort study included patients with COPD between January 2004 and December 2019. The participants were divided into four groups based on visually detected emphysema and impaired DL<sub>CO</sub>. Among 597 patients with COPD, 8.5% had no emphysema and impaired DL<sub>CO</sub> whereas 36.3% had emphysema without impaired DL<sub>CO</sub>. Among the four groups, patients with impaired DL<sub>CO</sub> and emphysema showed a higher risk of moderate-to-severe or severe exacerbation than those with normal DL<sub>CO</sub>. Impaired DL<sub>CO</sub> was an independent risk factor for severe exacerbation (hazard ratio, 1.524 [95% confidence interval 1.121-2.072]), whereas the presence of emphysema was not. The risk of moderate-to-severe or severe exacerbation increases with the severity of impaired DL<sub>CO</sub>. After propensity-score matching for the extent of emphysema, impaired DL<sub>CO</sub> was significantly associated with a higher risk of moderate-to-severe (p = 0.041) or severe exacerbation (p = 0.020). In patients with COPD and heterogeneous parenchymal abnormalities, DL<sub>CO</sub> can be considered an independent biomarker of acute exacerbation.
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.